Atomo Diagnostics
Atomo Diagnostics design and manufactures blood-based, lateral flow rapid diagnostic test (RDT) devices.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | $272k | Post IPO Equity |
| Total Funding | 000k | ||
TEN13(exited)
Sydney Angels(exited)
Bill & Melinda Gates Foundation(exited)
Transition Level Investments(exited)
Advance Queensland(exited)
Alium Capital Management(exited)
| AUD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 25 % | 84 % | (79 %) | 61 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (60 %) | (70 %) | (30 %) | (366 %) | (115 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (172 %) | (90 %) | (46 %) | (391 %) | (168 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 13 % | 12 % | 11 % | 24 % | 6 % |
Source: Company filings or news article
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.